Cbdmd Inc Revenue Growth Rates (YCBD), Current and Historic Growth - CSIMarket
CSIMarket
 


Cbdmd Inc   (NYSEAMER: YCBD)
 

YCBD's Revenue Growth by Quarter and Year

Cbdmd Inc 's Revenue results by quarter and year




YCBD Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter September -
3rd Quarter June 5.55
2nd Quarter March 5.64
1st Quarter December 5.02
FY 16.21

YCBDs Annual Revenue
Cbdmd Inc 's Revenue in the fiscal year 2025 $ 19.19 millions
Cbdmd Inc 's Revenue in the fiscal year 2024 $ 19.48 millions
Cbdmd Inc 's Revenue in the fiscal year 2023 $ 24.16 millions
Cbdmd Inc 's Revenue in the fiscal year 2022 $ 35.40 millions
Cbdmd Inc 's Revenue in the fiscal year 2021 $ 44.48 millions




YCBD Revenue third quarter 2026 Y/Y Growth Comment
Cbdmd Inc achieved in the third quarter 2026, above Company average Revenue growth of 20.47% year on year, to $ 5.55 millions.

Looking into third quarter 2026 results within Personal & Household Products industry 16 other companies have achieved higher Revenue growth. While Cbdmd Inc ' s Revenue rise of 20.47% ranks overall at the positon no. 2888 in the third quarter 2026.




YCBD Revenue ( Y/Y Growth %) 2026
2025 2024 2023
4th Quarter September - 3.51 % -20.14 % -27.35 %
3rd Quarter June 20.47 % -10.83 % -15.52 % -28.75 %
2nd Quarter March 18.74 % 8.45 % -29.81 % -35.2 %
1st Quarter December -1.76 % -5.02 % -11.66 % -34.66 %
FY   - -1.54 % -19.33 % -

Financial Statements
Cbdmd Inc 's third quarter 2026 Revenue $ 5.55 millions YCBD's Income Statement
Cbdmd Inc 's third quarter 2025 Revenue $ 4.61 millions Quarterly YCBD's Income Statement


YCBD Revenue (Quarter on Quarter Growth %)

2026
2025 2024 2023
4th Quarter September - 2.39 % -11.8 % -6.7 %
3rd Quarter June -1.53 % -2.95 % 18.04 % -1.92 %
2nd Quarter March 12.35 % -7.05 % -18.59 % 2.46 %
1st Quarter December 6.36 % 12.06 % -5.78 % -22.52 %
FY (Year on Year)   - -1.54 % -19.33 % -




Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Personal & Household Products Industry #17
Consumer Non Cyclical Sector #117
Overall #2888

Revenue Y/Y Growth Statistics
High Average Low
93.86 % 3.01 % -31.77 %
(Jun 30 2019)   (Sep 30 2023)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Personal & Household Products Industry #17
Consumer Non Cyclical Sector #117
Overall #2888
Revenue Y/Y Growth Statistics
High Average Low
93.86 % 3.01 % -31.77 %
(Jun 30 2019)   (Sep 30 2023)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Cbdmd Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
1110.35 % 46.56 % -100 %
(Mar 31 2019)  


YCBD's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Cbdmd Inc disclosed decrease in Revenue from the second quarter by -1.53% to $ 5.55 millions, from $ 5.64 millions achived in the previous reporting period.

But that's not important problem, as Cbdmd Inc 's Revenue generally seem to plunge in this quarter.

Within Personal & Household Products industry 7 other companies have achieved higher Revenue quarter on quarter growth. While Cbdmd Inc 's Revenue growth quarter on quarter, overall rank is 2070.


Revenue Q/Q Growth Company Ranking
Within: No.
Personal & Household Products Industry #8
Consumer Non Cyclical Sector #65
Overall #2070
Revenue Q/Q Growth Company Ranking
Within: No.
Personal & Household Products Industry #8
Consumer Non Cyclical Sector #65
Overall #2070
Revenue Q/Q Growth Statistics
High Average Low
1110.35 % 46.56 % -100 %
(Mar 31 2019)  


YCBD's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Cbdmd Inc disclosed decrease in Revenue from the second quarter by -1.53% to $ 5.55 millions, from $ 5.64 millions achived in the previous reporting period.

But that's not important problem, as Cbdmd Inc 's Revenue generally seem to plunge in this quarter.

Within Personal & Household Products industry 7 other companies have achieved higher Revenue quarter on quarter growth. While Cbdmd Inc 's Revenue growth quarter on quarter, overall rank is 2070.


Cbdmd Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)
12 Months Ending
(Mar 31 2026)
12 Months Ending
(Dec 31 2025)
12 Months Ending
(Sep 30 2025)
12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 20.93 $ 19.98 $ 19.09 $ 19.19 $ 19.03
Y / Y Revenue Growth (TTM) 10.01 % 2 % -0.66 % -1.5 % -7.8 %
Year on Year Revenue Growth Overall Ranking # 3132 # 2700 # 2972 # 3003 # 2919
Seqeuential Revenue Change (TTM) 4.74 % 4.66 % -0.5 % 0.86 % -2.89 %
Seq. Revenue Growth (TTM) Overall Ranking # 2888 # 2066 # 2353 # 2600 # 2428


Cumulative Revenue growth Comment
Cbdmd Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 10.01% year on year, to $ 21 millions if the fiscal year would have ended in Jun 30 2026.
Cbdmd Inc 's trailing twelve months Revenue growth was higher than company's average 3.01% and higher than 2% growth in Mar 31 2026.
But from twelve months ended Mar 31 2026 rise was beneth at 4.74 % from $19.98 millions achieved in the period from Mar 31 2026 to Jun 30 2025.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 3.01%.
The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 4.74 % increase from $19.98 millions in the period from Mar 31 2026 to Jun 30 2025.

In the Consumer Non Cyclical sector 129 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2700 to 3132.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Personal & Household Products Industry # 17
Consumer Non Cyclical Sector # 130
Overall # 3132

Revenue TTM Y/Y Growth Statistics
High Average Low
93.86 %
3.01 %
-31.77 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 17
Sector # 117
S&P 500 # 2888
Cumulative Revenue growth Comment
Cbdmd Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 10.01% year on year, to $ 21 millions if the fiscal year would have ended in Jun 30 2026.
Cbdmd Inc 's trailing twelve months Revenue growth was higher than company's average 3.01% and higher than 2% growth in Mar 31 2026.
But from twelve months ended Mar 31 2026 rise was beneth at 4.74 % from $19.98 millions achieved in the period from Mar 31 2026 to Jun 30 2025.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 3.01%.
The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 4.74 % increase from $19.98 millions in the period from Mar 31 2026 to Jun 30 2025.

In the Consumer Non Cyclical sector 129 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2700 to 3132.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Personal & Household Products Industry # 17
Consumer Non Cyclical Sector # 130
Overall # 3132

Revenue TTM Y/Y Growth Statistics
High Average Low
93.86 %
3.01 %
-31.77 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 17
Sector # 117
S&P 500 # 2888




Other Revenue Growth
Personal & Household Products Industry Revenue Growth Trends and Statistics
Consumer Non Cyclical Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
YCBD's Revenue Growth Ratio versus Personal & Household Products Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Jun 30 2026 within Consumer Non Cyclical SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
E l f Beauty Inc 35.59%$ 35.592 millions
Ispire Technology Inc32.55%$ 32.548 millions
Altria Group Inc 31.08%$ 31.081 millions
The Vita Coco Company Inc 28.32%$ 28.321 millions
Buda Juice Inc 26.38%$ 26.381 millions
Lifeway Foods Inc 25.27%$ 25.268 millions
Tradewinds Universal25.00%$ 25.000 millions
Mdwerks Inc 24.60%$ 24.603 millions
Senestech Inc 23.20%$ 23.200 millions
Turning Point Brands Inc 22.58%$ 22.583 millions
Crimson Wine Group Ltd 22.22%$ 22.220 millions
Local Bounti Corporation20.73%$ 20.729 millions
Cbdmd Inc 20.56%$ 20.555 millions
Monster Beverage Corp20.18%$ 20.179 millions
Cvr Partners Lp19.95%$ 19.954 millions
Cf Industries Holdings inc 17.57%$ 17.566 millions
CN Healthy Food Tech Group Corp.17.08%$ 17.076 millions
Freshpet Inc 15.67%$ 15.669 millions
Stepan Company15.19%$ 15.192 millions
Equator Beverage Company14.23%$ 14.226 millions
Brc Inc 13.64%$ 13.642 millions
Ecolab Inc 13.50%$ 13.505 millions
Edible Garden Ag Incorporated12.84%$ 12.842 millions
Suja Life Inc 11.56%$ 11.563 millions
Celsius Holdings Inc 10.70%$ 10.702 millions
Tofutti Brands Inc 10.51%$ 10.507 millions
Philip Morris International Inc 10.37%$ 10.375 millions


About Cbdmd Inc Revenue Growth Rates (YCBD), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Cbdmd Inc (CIK 1644903).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-26-027665
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Cbdmd Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.